New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Quest Diagnostics Incorporated
DGX
Shape
US Flag

NYSE

17B

Medical - Diagnostics & Research

Next Earning date - 22 Oct 2024

17B

Medical - Diagnostics & Research

Next Earning date - 22 Oct 2024

148.67USD
Shape0.86 ( 0.58%)
favorite-chart

Relative Strenght

64
favorite-chart

Volume Buzz

-61%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

7%

Quote Panel

Shape
Updated October 12, 2024
1W 1.20 % 1M -3.22 % 3M 3.33 % 1Y 23.97 %

Key Metrics

Shape
  • Market Cap

    16.55B


  • Shares Outstanding

    111.32M


  • Share in Float

    110.77M


  • Dividende

    3


  • Earning Date

    22 Oct 2024


  • Price Target

    148.67


  • Average Volume

    795428


  • Beta

    0.888


  • Range

    120.76-159.36


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.questdiagnostics.com


  • Sector

    Healthcare


Fundamentals

Shape

16.97x

P/E Ratio

1.77x

P/S Ratio

2.49x

P/B Ratio

0.7

Debt/Equity

9.0%

Net Margin

$7.4

EPS

How DGX compares to sector?

P/E Ratio

Relative Strength

Shape

DGX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$10B

Shape327%

2025-Revenue

$8.75

Shape327%

2025-EPS

$2B

Shape375%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Citigroup

upgrade

Previous: Neutral

2024-07-10

Now: Buy

Credit Suisse

downgrade

Previous: Not converted

2023-04-03

Now: Neutral

Goldman Sachs

upgrade

Previous: Not converted

2023-04-03

Now: Buy

Barclays

downgrade

Previous: Not converted

2023-04-03

Now: Equal-Weight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-40%

2.36
vs 3.96

Q4.22

arrow
arrow

-41%

1.98
vs 3.33

Q1.23

arrow
arrow

-37%

2.04
vs 3.22

Q2.23

arrow
arrow

-3%

2.3
vs 2.36

Q3.23

arrow
arrow

-6%

2.22
vs 2.36

Q4.23

arrow
arrow

+9%

2.15
vs 1.98

Q1.24

arrow
arrow

N/A

2.04
vs 2.04

Q2.24

arrow
arrow

+2%

2.35
vs 2.3

Q3.24

arrow
arrow

+2%

2.27
vs 2.22

Q4.24

arrow
arrow

+3%

2.22
vs 2.15

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-10%

2.5B  vs 2.8B

Q4.22

arrow
arrow

-15%

2.3B  vs 2.7B

Q1.23

arrow
arrow

-11%

2.3B  vs 2.6B

Q2.23

arrow
arrow

-5%

2.3B  vs 2.5B

Q3.23

arrow
arrow

-8%

2.3B  vs 2.5B

Q4.23

arrow
arrow

-2%

2.3B  vs 2.3B

Q1.24

arrow
arrow

+2%

2.4B  vs 2.3B

Q2.24

arrow
arrow

+3%

2.4B  vs 2.3B

Q3.24

arrow
arrow

+5%

2.4B  vs 2.3B

Q4.24

arrow
arrow

+8%

2.5B  vs 2.3B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+4%

0.04
vs 0.04

Q4.22

arrow
arrow

+2%

0.02
vs 0.04

Q1.23

arrow
arrow

+3%

0.03
vs 0.02

Q2.23

arrow
arrow

+4%

0.04
vs 0.03

Q3.23

arrow
arrow

+4%

0.04
vs 0.04

Q4.23

arrow
arrow

+3%

0.03
vs 0.04

Q1.24

arrow
arrow

+3%

0.03
vs 0.03

Q2.24

arrow
arrow

+3%

0.03
vs 0.03

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

818

818
vs 864

-5%

Q4.22

arrow
arrow

901

901
vs 818

10%

Q1.23

arrow
arrow

846

846
vs 901

-6%

Q2.23

arrow
arrow

833

833
vs 846

-2%

Q3.23

arrow
arrow

815

815
vs 833

-2%

Q4.23

arrow
arrow

842

842
vs 815

3%

Q1.24

arrow
arrow

825

825
vs 842

-2%

Q2.24

arrow
arrow

835

835
vs 825

1%

Earnings Growth

Latest News